VADS INDUCE-3 (GSK-209229) Study of GSK3359609 and Pembrolizumab in Programmed Death Receptor 1-ligand 1 Positive Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (INDUCE-3) Paris CHRISTOPHE LE TOURNEAU
VADS INDUCE-4 (GSK-209227) A Randomized, Double-Blind, Adaptive, Phase II/III Study of GSK3359609 in Combination With Pembrolizumab and 5FU-Platinum Chemotherapy Versus Placebo in Combination With Pembrolizumab Plus 5FU-Platinum Chemotherapy for First-Line Treatment of Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma. Paris CHRISTOPHE LE TOURNEAU
Appareil pulmonaire MARIPOSA (73841937NSC3003) A Phase 3, Randomized Study of Amivantamab and Lazertinib Combination Therapy;Versus Osimertinib Versus Lazertinib as First-Line Treatment in Patients with;EGFR-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer;MARIPOSA Paris NICOLAS GIRARD
Pédiatrie Tumeurs cérébrales NIVOGLIO Phase I-II study of nivolumab in combination;with temozolomide and radiotherapy;in children and adolescents;with newly diagnosed high-grade glioma Paris FRANCOIS DOZ
Sein métastatique RH+ PALATINE - UC-0140/1814 ADVANCED BREAST CANCER: THERAPY INTEGRATING LOCOREGIONAL TREATMENT IN DE NOVO,;TREATMENT NAIVE, STAGE IV ER+, HER2- BREAST CANCER PATIENTS RECEIVING LETROZOLE AND;PALBOCICLIB Paris, Saint-Cloud
Appareil Digestif REGIRI (PRODIGE 58) A randomised phase II trial assessing REGorafenib combined with IRInotecan as second-line treatment in patients with metastatic gastro-oesophageal adenocarcinomas Paris, Saint-Cloud
Appareil Digestif SAMCO (FFCD1603-PRODIGE 54) Multicenter Randomized Phase II Study Comparing the Effectiveness and Tolerance of Avelumab Versus Standard 2nd Line Treatment Chemotherapy in Patients With Colorectal Metastatic Cancer With Microsatellite Instability (MSI). Paris BRUNO BUECHER
Appareil pulmonaire TRIZELL rAd-IFN-MM-301 A Phase 3, Open-Label, Randomized, Parallel Group Study to Evaluate the Efficacy and Safety of Intrapleural Administration of Adenovirus-Delivered Interferon Alpha-2b (rAd-IFN) in Combination With Celecoxib and Gemcitabine in Patients With Malignant Pleural Mesothelioma Paris NICOLAS GIRARD
Appareil pulmonaire AMG20190294 A Non-interventional Biomarker Study on the;Molecular Evaluation of Archival Tumor Tissue in;Subjects with Non-Small Cell Lung Cancer;(NSCLC) Paris NICOLAS GIRARD
Appareil pulmonaire GeoMETry-III (CINC280A2301) A phase III, randomized, controlled, open-label, multicenter,;global study of capmatinib versus SoC docetaxel;chemotherapy in previously treated patients with EGFR wt,;ALK negative, locally advanced or metastatic (stage IIIB/IIIC;or IV) NSCLC harboring MET exon 14 skipping mutation;(METÀex14) Paris CATHERINE DANIEL